ValueMax - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
04/02/26	DBS Vickers	ValueMax	1.08	1.45	Buy	PER11x FY26

UOL - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
03/14/25	CIMB	UOL	5.76	8.2	Add	RNAV
03/26/25	DBS Vickers	UOL	5.8	8.5	Buy	RNAV (40% disc)
05/20/25	DBS Vickers	UOL	5.74	8.4	Buy	RNAV (40% disc)
06/05/25	DBS Vickers	UOL	6.02	8.4	Buy	RNAV (40% disc)
07/02/25	CIMB	UOL	6.56	8.2	Add	RNAV
07/02/25	Citi Research	UOL	6.56	9.6	Buy	RNAV (40% disc)
08/14/25	CIMB	UOL	7.16	8.2	Add	RNAV
08/18/25	Lim & Tan	UOL	7.27	8.06	Buy
08/20/25	DBS Vickers	UOL	7.19	8.8	Buy	RNAV (40% disc)
08/20/25	Lim & Tan	UOL	7.19	8.11	Buy
09/05/25	CLSA	UOL	7.25	10.5	Outperform
09/11/25	DBS Vickers	UOL	7.4	8.8	Buy	RNAV (40% disc)
09/11/25	Lim & Tan	UOL	7.4	8.37	Buy
09/11/25	Citi Research	UOL	7.4	9.6	Buy	RNAV (40% disc)
10/03/25	Lim & Tan	UOL	8	8.37	Buy
10/08/25	DBS Vickers	UOL	8.02	8.8	Buy	RNAV (40% disc)
10/08/25	JPM	UOL	8.02	10.15	Overweight
11/18/25	OCBC	UOL	8.65	10.06	Buy	RNAV
12/04/25	DBS Vickers	UOL	8.68	8.8	Buy	RNAV (40% disc)
12/05/25	Lim & Tan	UOL	8.62	0	Accumulate
01/26/26	JPM	UOL	10.3	12.05	Overweight
02/02/26	DBS Vickers	UOL	10.84	13	Buy	RNAV (25% disc)
02/27/26	DBS Vickers	UOL	10.68	17.5	Buy	RNAV (25% disc)
02/27/26	OCBC	UOL	10.68	12.87	Buy	RNAV
02/27/26	Lim & Tan	UOL	10.68	11.42	Hold
03/16/26	JPM	UOL	10.3	9.55	Neutral
03/16/26	Citi Research	UOL	10.3	12.9	Buy	RNAV (27% disc)
03/17/26	CIMB	UOL	9.76	12.83	Add
04/02/26	DBS Vickers	UOL	9.95	13	Buy	RNAV (25% disc)
04/20/26	JPM	UOL	10.16	12	Overweight

UOB Kay Hian - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
04/23/25	Lim & Tan	UOB Kay Hian	1.77	0	Buy
06/13/25	Lim & Tan	UOB Kay Hian	1.97	0	Accumulate
01/19/26	Macquarie	UOB Kay Hian	2.68	3.12	Outperform	PER10.5x FY27

Stock calls for 30 June 2026

Date	Analyst	Company	Last	Target	Call	Valuation
06/30/26	Amfrasers	Attika	0.165	0.312	Outperform	DCF
06/30/26	UOB Kay Hian	Keppel DC Reit	2.26	2.99	Buy	DDM
06/30/26	Lim & Tan	Mapletree Commercial	1.3	1.52	Hold
06/30/26	Amfrasers	Skylink	0.22	0.58	Outperform	DCF
06/30/26	CIMB	Wee Hur	0.655	0.95	Add	Sum of parts

The covid aftermath in Singapore and its repercussions.

A June US hearing had revealed that mRNA vaccination could cause cancer and heart attacks, and also unsafe for humans.

Let's look at the aftermath of covid in Singapore after the adoptions of the co-exist covid policy and mRNA vaccination.

Singapore cancer diagnoses spiked after our co-exist policy and mRNA vaccination.  Besides the mRNA vaccination, covid inflammation can also increase the risk of cancer.

Simultaneously, Singapore chronic kidney diseases also spiked (+60%) alongside the cancer diagnoses.

This spike could be due to our co-exist policy because multiple covid infections and long covid would increase the risk of kidney failure.

We had stated previously that zero covid policy was better than the co-exist policy, and china became the winner because it was the last country to open up.  Furthermore, China protected its citizens by not using mRNA vaccines on its people.  In the end, China and its people suffered the least covid damages.

https://sg-stock.blogspot.com/2022/10/is-co-exist-policy-or-zero-covid-policy.html

UOB - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
03/12/25	Citi Research	UOB	37.35	36.9	Hold	GGM, PB1.3x FY25
03/12/25	Jefferies	UOB	37.35	43	Buy
03/12/25	DBS Vickers	UOB	37.35	38.5	Hold
03/21/25	phillip	UOB	37.8	41.8	Accumulate	GGM, PB1.49x FY25
03/24/25	Lim & Tan	UOB	37.95	42.5	Accumulate
03/24/25	MorningStar	UOB	37.95	37.6	Hold
04/03/25	DMG & Partners	UOB	36.17	41.6	Buy	GGM, PB1.38x FY25
04/07/25	Lim & Tan	UOB	35.46	0	Hold
04/07/25	Citi Research	UOB	35.46	34.8	Hold
04/08/25	DBS Vickers	UOB	33.23	32.7	Hold	GGM, PB1x FY26
04/10/25	Kim Eng	UOB	30.99	32.02	Hold
04/21/25	CIMB	UOB	34.8	38.8	Add
04/22/25	DMG & Partners	UOB	35.3	37.6	Neutral
05/07/25	DBS Vickers	UOB	34.98	32.7	Hold	GGM, PB1x FY26
05/07/25	CIMB	UOB	34.98	38.6	Add	GGM
05/07/25	Lim & Tan	UOB	34.98	38.8	Hold
05/07/25	MorningStar	UOB	34.98	39	Buy	GGM, PB1.3x FY25
05/09/25	phillip	UOB	34.55	35.5	Accumulate	GGM, PB1.26x FY25
05/09/25	MorningStar	UOB	34.55	37.5	Hold
05/19/25	Jefferies	UOB	35.5	40	Buy
06/06/25	Citi Research	UOB	35.21	34.7	Hold	GGM, PB1.2x FY25/26
06/10/25	CIMB	UOB	35.33	38.6	Add	GGM
06/12/25	phillip	UOB	35.12	36.3	Accumulate
06/19/25	Lim & Tan	UOB	34.83	37.99	Accumulate
07/07/25	phillip	UOB	36.12	36.3	Accumulate
07/15/25	CIMB	UOB	36.88	38.6	Add	GGM
08/07/25	DBS Vickers	UOB	36.45	32.7	Hold	GGM, PB1x FY26
08/07/25	Lim & Tan	UOB	36.45	38.27	Hold
08/08/25	DBS Vickers	UOB	35.81	33.9	Hold	GGM, PB1x FY26
08/08/25	Kim Eng	UOB	35.81	38.36	Hold	DDM
08/08/25	CIMB	UOB	35.81	38.3	Hold	GGM
08/08/25	OCBC	UOB	35.81	38.2	Hold	Cut from $41.50
08/11/25	phillip	UOB	35.7	34.6	Neutral	GGM, PB1.23x FY25
08/11/25	Lim & Tan	UOB	35.7	0	Hold
08/11/25	JPM	UOB	35.7	36.5	Neutral
08/11/25	Citi Research	UOB	35.7	34.8	Hold
10/17/25	DBS Vickers	UOB	34.58	33.9	Hold	GGM, PB1x FY26
10/21/25	phillip	UOB	34.3	34.6	Accumulate	GGM, PB1.23x FY25
10/21/25	Citi Research	UOB	34.3	34.5	Hold
11/06/25	Lim & Tan	UOB	34.87	37.24	Accumulate on weakness
11/06/25	Citi Research	UOB	34.87	33.7	Hold
11/07/25	phillip	UOB	33.9	30.4	Neutral	GGM, PB1.08x FY25
11/07/25	DBS Vickers	UOB	33.9	33.9	Hold	GGM, PB1x FY26
11/10/25	DMG & Partners	UOB	33.86	36.1	Buy	Cut from $38.80
01/09/26	JPM	UOB	36.01	34	Neutral
01/26/26	phillip	UOB	39.5	36.7	Neutral
01/27/26	CIMB	UOB	38.5	40.9	Hold	GGM
02/16/26	Citi Research	UOB	38.47	39	Hold	GGM, PB1.3x FY26
02/24/26	DBS Vickers	UOB	38.8	35.7	Hold	GGM, PB1.1x FY26
02/24/26	Lim & Tan	UOB	38.8	0	Hold
02/25/26	OCBC	UOB	37.2	41	Hold
02/26/26	phillip	UOB	36.98	37	Neutral	GGM, PB1.26x FY26
03/20/26	Lim & Tan	UOB	37.16	39	Accumulate on weakness
04/16/26	CIMB	UOB	37.59	38.7	Hold	GGM
04/23/26	DMG & Partners	UOB	37.02	39.5	Buy
05/06/26	DBS Vickers	UOB	36.28	35.7	Hold	GGM, PB1.1x FY26
05/07/26	Lim & Tan	UOB	36.65	39	Accumulate
05/08/26	phillip	UOB	36.7	37	Neutral	GGM, PB1.26x FY26
05/08/26	OCBC	UOB	36.7	41	Buy
06/08/26	phillip	UOB	38.55	39	Neutral